• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on September 28, 2023January 2, 2024

Request for Review: Autoimmune Hepatitis Case Definition

On behalf of the Brighton Collaboration Autoimmune Hepatitis Case Definition Working Group, please find below a manuscript on “A...
Read More
Posted on May 2, 2023September 21, 2023

BC Peer Review Needed: B-R Assessment Manuscript and Case Study

Digital,digital
Read More
Posted on March 12, 2023September 20, 2023

Maternal Immunization Working Group Meeting Report (November 2022)

On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectiv...
Read More
Posted on February 17, 2023August 9, 2023

Reactivation of the Brighton Collaboration Digital Innovations in Vaccine Safety (DIVaS) Working Group

Digital,digital
Read More
Posted on December 19, 2022October 23, 2023

CEPI expands partnership with Brighton Collaboration to support safety assessment of vaccine candidates

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration, based in Atlanta at The Task Force fo...
Read More
Posted on November 11, 2022August 9, 2023

COVID-19 AESI List 5th Update – October 2022

SPEAC has completed a fifth update to the Priority List of potential Adverse events of special interest relevant to COVID-19 vacci...
Read More
Posted on September 23, 2022August 9, 2023

International Society of Pharmacoepidemiology (ISPE) COVID19-related Award: Robert T. Chen MD MA FISPE

We are proud to announce that Dr. Bob Chen, Scientific Director of the Brighton Collaboration, received a special award for “Co...
Read More
Posted on July 28, 2022June 26, 2023

Director of Research – Brighton Collaboration

To help meet its increasing needs, the Secretariat for the Brighton Collaboration (BC) has recently posted a new staff position:...
Read More
Posted on February 9, 2022August 9, 2023

CEPI Sponsored DSMB Training Course

Coalition for Epidemic Preparedness Innovations (CEPI) through the Safety Platform for Emergency vACcines (SPEAC) project, has f...
Read More
Posted on January 25, 2022June 27, 2023

WHO & COVAX Vaccine Safety Working Group Active Vaccine Safety Surveillance Survey

On behalf of the COVAX Vaccine Safety Working group: After COVID-19 vaccines are introduced into countries, it will be vital to...
Read More
Previous page 1 2 3 4 5 Next page

Recent Posts

  • Request for Review: Acute Multi-Organ Dysfunction (aMOD) Brighton Case DefinitionFebruary 4, 2026
  • In Memory of Dr. William FoegeJanuary 27, 2026
  • Brighton Collaboration News — December 2025December 18, 2025
  • Request for Review: Acute Intraocular Inflammation Draft Brighton Case DefinitionAugust 25, 2025
  • Standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa feverJune 2, 2025

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy